FIELD: biotechnology.
SUBSTANCE: the invention relates to biotechnology, food industry and cosmetology and is a composition for promoting the biosynthesis of elastin or collagen. The composition improves the ability of fibroblasts to biosynthesize elastin and collagen and is therefore used to restore the elasticity of skin degraded due to aging or exposure to light, remove facial wrinkles and wrinkles, improve vascular elasticity degraded due to aging, and treat hypertension and reduced blood flow caused by it, and strengthening the elasticity of tendons and ligaments and the elasticity of the joints.
EFFECT: the composition improves the ability of fibroblasts to biosynthesize elastin and collagen.
14 cl,3 dwg, 2 tbl,3 ex
| Title |
Year |
Author |
Number |
| AMINO ACID-BASED COMPOSITION FOR RECOVERING FIBROELASTINE IN DERMAL CONNECTIVE TISSUES |
2015 |
|
RU2704032C2 |
| MICROCAPSULE INCLUDING A PEPTIDE WITH A CELL RECEPTOR BINDING AFFINITY AND A COSMETIC COMPOSITION CONTAINING IT |
2018 |
- Khan, Sang Keun
- Li, Khiun Sook
- Kim, Eun Akh
- Khiun, Seung Min
- Choi, Khieong
- Baek, So Joon
- Khong, Dzae Khva
- Lim, Chae Mi
- Bak, Da Dzeong
- Dzo, Khie Dzin
- Li, Khak Sung
- Park, Dzi Khun
- Li, Eun Joung
|
RU2743036C1 |
| GENE-THERAPEUTIC DNA-VECTOR BASED ON GENE-THERAPEUTIC DNA-VECTOR VTVAF17, CARRYING TARGET GENE SELECTED FROM GROUP OF GENES COL1A1, COL1A2, P4HA1, P4HA2, COL7A1, CLCA2, ELN, PLOD1 TO INCREASE LEVEL OF EXPRESSION OF SAID TARGET GENES, METHOD FOR PRODUCTION AND USE THEREOF, STRAIN ESCHERICHIA COLI SCS110-AF/VTVAF17-COL1A1, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-COL1A2, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-P4HA1, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-P4HA2, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-COL7A1, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-CLCA2, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-ELN, OR ESCHERICHIA COLI SCS110-AF/VTVAF17- PLOD1, CARRYING GENE-THERAPEUTIC DNA VECTOR, METHOD FOR PRODUCTION THEREOF, METHOD FOR INDUSTRIAL PRODUCTION OF GENE-THERAPEUTIC DNA VECTOR |
2018 |
|
RU2730661C2 |
| COMPOSITION FOR EVALUATING, PREVENTING, OR REDUCING SKIN AGING USING HAPLN1 |
2017 |
- Kim, Dae Kyong
- Fu, Zhicheng
- Back, Moon Jung
|
RU2750486C2 |
| PEPTIDE FOR THE PREVENTION OF SKIN DAMAGE CAUSED BY ATMOSPHERIC POLLUTION AND FOR ANTI-AGING THERAPY, AS WELL AS ITS USE |
2019 |
- Chung, Yong Ji
- Kim, Eun Mi
- Lee, Eung Ji
|
RU2773534C1 |
| METHOD OF PRODUCING TRIPEPTIDE CONTAINING OLEANOLIC ACID AND ITS THERAPEUTIC APPLICATIONS |
2018 |
- Majeed Muhammed
- Nagabhushanam Kalyanam
- Mundkur Lakshmi
- Ramanujam Rajendran
|
RU2733372C1 |
| INJECTED MEDICAL COMPOSITION |
2021 |
- Mironova Iuliia Aleksandrovna
- Prokopov Aleksei Iurevich
|
RU2788726C1 |
| BIFUNCTIONAL PEPTIDE |
2013 |
- Hornebeck William
- Attia Joan
- Lorimier Sandrine
- Antonicelli Frank
|
RU2639573C2 |
| COSMETIC FOR SKIN |
2021 |
|
RU2780260C1 |
| COSMETIC OR DERMATOLOGICAL COMPOSITIONS COMBINING RETINALDEHYDE AND GLYCYLGLYCINE OLEAMIDE AND COSMETIC OR DERMATOLOGICAL USES THEREOF |
2014 |
- Bakkevill Daniel
- Bogdanovich Patrik
- Sora Zhan-Iler
- Sorg Olive
|
RU2660359C2 |
